Literature DB >> 11704348

Mechanisms of MPP(+) incorporation into cerebellar granule cells.

R A González-Polo1, A Mora, N Clemente, G Sabio, F Centeno, G Soler, J M Fuentes.   

Abstract

Exposure of cerebellar granule cells to 1-methyl-4-phenylpiridinium (MPP(+)) results in cell death. We have studied the implication of various membrane transporter systems on MPP(+) neurotoxicity, including the dopamine transporter system (DAT) and cationic amino acid transporters (CAT). We have showed a partial protection against MPP(+) toxicity when the dopamine transporter is inhibited by 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]4-(3-phenylpropyl)piperazinedihydrochloride (GBR-12909). However, almost full protection is only achieved by the simultaneous addition of GBR-12909 and cationic amino acids. These results suggest two ways system of MPP(+) entrance into cerebellar granule cells: the DAT with high activity and the CAT with low activity. We also demonstrated that 5,7-dichlorokynurenic acid (MK-801) failed to protect against MPP(+) exposure, evidencing that N-methyl-D-aspartate (NMDA) receptor is not involved in the MPP(+)-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704348     DOI: 10.1016/s0361-9230(01)00610-4

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

1.  Calpain plays a central role in 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in cerebellar granule neurons.

Authors:  Richard A Harbison; Kristen R Ryan; Heather M Wilkins; Emily K Schroeder; F Alexandra Loucks; Ron J Bouchard; Daniel A Linseman
Journal:  Neurotox Res       Date:  2010-03-24       Impact factor: 3.911

Review 2.  MPP+: mechanism for its toxicity in cerebellar granule cells.

Authors:  Rosa A González-Polo; Germán Soler; José M Fuentes
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

3.  Pharmacological characterization and anatomical distribution of the dopamine transporter in the mouse cerebellum.

Authors:  Foteini Delis; Ada Mitsacos; Panagiotis Giompres
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

4.  Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

Authors:  S Samantaray; V H Knaryan; C Le Gal; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

5.  Binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a metabolite of haloperidol, to synthetic melanin: implications for the dopaminergic neurotoxicity of HPP+.

Authors:  Hidekazu Kawashima; Yasuhiko Iida; Youji Kitamura; Hideo Saji
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  Circular RNA hsa_circ_0004381 Promotes Neuronal Injury in Parkinson's Disease Cell Model by miR-185-5p/RAC1 Axis.

Authors:  Hongying Zhang; Cuihui Wang; Xuejie Zhang
Journal:  Neurotox Res       Date:  2022-06-20       Impact factor: 3.978

7.  Effects of estradiol, phytoestrogens, and Ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress.

Authors:  Benoit Gagné; Sylvie Gélinas; Geneviève Bureau; Bruno Lagacé; Charles Ramassamy; Keith Chiasson; Barbara Valastro; Maria-Grazia Martinoli
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

8.  Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.

Authors:  Keith Chiasson; Benoît Daoust; Daniel Levesque; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.978

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.